InMed Pharmaceuticals Inc. (INM)

CIK 1728328 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for InMed Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001062993-26-005760
Nov 5, 20268-K0001193125-26-448367
Nov 3, 202610-Q0001213900-26-115083
Nov 3, 20268-K0001062993-26-005723
Nov 2, 20264250001193125-26-443834
Oct 28, 2026424B30001193125-26-436382
Oct 27, 20264250001193125-26-432362
Oct 27, 202640001940272-26-000028
Oct 20, 202640001940272-26-000026
Oct 15, 202640001940272-26-000025
Oct 8, 202640001940272-26-000023
Oct 7, 2026SCHEDULE 13G/A0001104659-26-114415
Oct 5, 202640001940272-26-000022
Oct 1, 2026424B30001193125-26-410691
Oct 1, 2026EFFECT9999999995-26-003126
Sep 29, 2026S-4/A0001193125-26-407792
Sep 18, 20268-K0001213900-26-101492
Sep 16, 202640001940272-26-000021
Sep 9, 2026S-4/A0001193125-26-386611
Sep 9, 202610-K0001213900-26-098419
Sep 9, 20264250001213900-26-098432
Aug 14, 2026SCHEDULE 13G0001193125-26-352958
Jul 22, 20264250001213900-26-080423
Jul 22, 20268-K0001213900-26-080414
Jul 22, 20264250001213900-26-080417